Koers Myriad Genetics, Inc.
Aandelen
MYGN
US62855J1043
Medische apparatuur, benodigdheden & distributie
Geschatte realtime
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
22,52 USD | +0,83% | -1,10% | +17,29% |
Omzet 2024 * | 831 mln. 765 mln. | Omzet 2025 * | 897 mln. 825 mln. | Marktkapitalisatie | 2,02 mld. 1,86 mld. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -92 mln. -84,64 mln. | Nettowinst (verlies) 2025 * | -64 mln. -58,88 mln. | EV/omzet 2024 * | 2,32 x |
Nettoliquiditeiten 2024 * | 93,93 mln. 86,42 mln. | Nettoliquiditeiten 2025 * | 116 mln. 107 mln. | EV/omzet 2025 * | 2,12 x |
K/w-verhouding 2024 * |
-23,8
x | K/w-verhouding 2025 * |
-31,9
x | Werknemers | 2.700 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 97,91% |
Recentste transcriptie over Myriad Genetics, Inc.
1 dag | +0,83% | ||
1 week | -1,10% | ||
Lopende maand | -1,36% | ||
1 maand | +12,42% | ||
3 maanden | +0,99% | ||
6 maanden | +22,74% | ||
Lopend jaar | +17,29% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Paul Diaz
CEO | Chief Executive Officer | 61 | 13-08-20 |
Scott Leffler
DFI | Director of Finance/CFO | 49 | 29/01 |
Dale Muzzey
CTO | Chief Tech/Sci/R&D Officer | 44 | 01-04-14 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
S. Phanstiel
CHM | Chairman | 65 | 16-09-09 |
Paul Bisaro
BRD | Director/Board Member | 63 | 31-10-22 |
Dan Spiegelman
BRD | Director/Board Member | 65 | 27-05-20 |
Naam | Gewicht | Volume | Vaira. 1 jan. | belegger rating |
---|---|---|---|---|
1.24% | 14 M€ | -4,50% | ||
0.26% | 2 M€ | -.--% |
Datum | Koers | Variatie | Volume |
---|---|---|---|
05-06-24 | 22,45 | +0,49% | 128 879 |
04-06-24 | 22,34 | -0,04% | 828 642 |
03-06-24 | 22,35 | -1,80% | 944 210 |
31-05-24 | 22,76 | +1,34% | 597 434 |
30-05-24 | 22,46 | -1,06% | 576 077 |
uitgestelde koers Nasdaq, 05 juni 2024 om 17:50 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+17,29% | 2,02 mld. | |
-5,37% | 12,35 mld. | |
-3,75% | 8,17 mld. | |
+7,79% | 5,77 mld. | |
+31,87% | 5,65 mld. | |
-12,12% | 4,1 mld. | |
+14,18% | 2,67 mld. | |
-5,70% | 2,31 mld. | |
-6,70% | 1,81 mld. | |
-3,89% | 1,51 mld. |